Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$1.6B |
| 2 |
American Express
AXP
|
$398M |
| 3 |
Capital One
COF
|
$151M |
| 4 |
Apollo Global Management
APO
|
$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
$109M |
Top Sells
| 1 |
Apple
AAPL
|
$1.16B |
| 2 |
Microsoft
MSFT
|
$873M |
| 3 |
Amazon
AMZN
|
$403M |
| 4 |
NVIDIA
NVDA
|
$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.23% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Gilead Sciences
GILD
$140B
| $348M | 0.24% | 4,510,200 -467,300 | -9% | -$36M |
|
77
Marsh & McLennan
MMC
$101B
| $336M | 0.23% | 1,788,100 -180,300 | -9% | -$33.9M |
|
78
Automatic Data Processing
ADP
$123B
| $329M | 0.22% | 1,496,400 -149,900 | -9% | -$32.9M |
|
79
Vertex Pharmaceuticals
VRTX
$100B
| $327M | 0.22% | 930,300 -88,500 | -9% | -$31.1M |
|
80
American Tower
AMT
$95.5B
| $326M | 0.22% | 1,683,100 -164,600 | -9% | -$31.9M |
|
81
CVS Health
CVS
$92.8B
| $320M | 0.22% | 4,622,260 -592,400 | -11% | -$41M |
|
82
Lam Research
LRCX
$127B
| $313M | 0.21% | 487,400 -54,000 | -10% | -$34.7M |
|
83
T-Mobile US
TMUS
$284B
| $302M | 0.21% | 2,176,002 -292,800 | -12% | -$40.7M |
|
84
Cigna
CI
$80.3B
| $301M | 0.2% | 1,072,801 -140,600 | -12% | -$39.5M |
|
85
Altria Group
MO
$113B
| $292M | 0.2% | 6,451,000 -661,500 | -9% | -$30M |
|
86
Shopify
SHOP
$184B
| $291M | 0.2% | 4,504,800 -275,100 | -6% | -$17.8M |
|
87
Eaton
ETN
$136B
| $289M | 0.2% | 1,437,500 -140,800 | -9% | -$28.3M |
|
88
Chubb
CB
$110B
| $288M | 0.2% | 1,495,791 -151,400 | -9% | -$29.2M |
|
89
Zoetis
ZTS
$69.3B
| $288M | 0.2% | 1,670,532 -179,200 | -10% | -$30.9M |
|
90
Fiserv
FI
$75.1B
| $284M | 0.19% | 2,250,486 -143,700 | -6% | -$18.1M |
|
91
Enbridge
ENB
$105B
| $284M | 0.19% | 7,619,531 -512,700 | -6% | -$19.1M |
|
92
Canadian Pacific Kansas City
CP
$69.9B
| $283M | 0.19% | 3,502,793 -232,800 | -6% | -$18.8M |
|
93
Uber
UBER
$196B
| $283M | 0.19% | 6,546,100 +609,900 | +10% | +$26.3M |
|
94
Boston Scientific
BSX
$156B
| $281M | 0.19% | 5,191,100 -493,200 | -9% | -$26.7M |
|
95
Progressive
PGR
$145B
| $280M | 0.19% | 2,114,300 -207,600 | -9% | -$27.5M |
|
96
Palo Alto Networks
PANW
$127B
| $279M | 0.19% | 1,093,000 -107,000 | -9% | -$27.3M |
|
97
Regeneron Pharmaceuticals
REGN
$61.5B
| $279M | 0.19% | 388,300 -36,700 | -9% | -$26.4M |
|
98
Southern Company
SO
$102B
| $277M | 0.19% | 3,942,200 -378,300 | -9% | -$26.6M |
|
99
Illinois Tool Works
ITW
$77.1B
| $275M | 0.19% | 1,100,900 -118,200 | -10% | -$29.6M |
|
100
Becton Dickinson
BDX
$55.3B
| $271M | 0.18% | 1,025,402 -99,300 | -9% | -$26.2M |
|